Physician

Alfred Jackson Newman, M.D.

According to 2025 Medicare claims, Alfred Newman, M.D. (NPI: 1831141548) practices hematology/oncology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is THE PRESBYTERIAN HOSPITAL (NPI: 1275256422; TIN: 560554230) and primary practice location at 28105-4658. Newman is affiliated with the Novant Health Accountable Care Organization I, LLC (ACO ID: A3504), participating under the MSSP model.

Newman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 251 traditional Medicare patients, billed 1,167 HCPCS/CPT codes, and received $66,115 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 557 prescription claims across 122 beneficiaries totaling $1,367,931 in drug costs, led by Lumakras (Sotorasib). 2019 DME data shows 13 claims. Open Payments data shows 3 records totaling $19,564. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	348	1,283	$83,724
2016	330	1,304	$80,965
2017	347	1,278	$83,121
2018	364	1,348	$89,552
2019	359	1,209	$82,593
2020	309	1,025	$71,397
2021	298	927	$80,369
2022	275	770	$66,694
2023	241	682	$61,300
2024	251	1,167	$66,115

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	146	1,211	$1,553,371
2016	158	1,285	$1,652,256
2017	159	1,141	$1,486,811
2018	157	1,081	$1,692,546
2019	161	1,001	$1,621,762
2020	159	934	$1,488,546
2021	140	863	$1,681,036
2022	110	596	$1,978,942
2023	115	584	$1,491,778
2024	122	557	$1,367,931

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	58	$33,484
2016	N/R	12	$12,347
2017	N/R	N/R	N/R
2018	N/R	35	$6,061
2019	N/R	13	$1,251
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	27	28	$124
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	43	43	$121
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	109	289	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	146	296	$65
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	168	471	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumakras	Sotorasib	13	390	$257,957
Tagrisso	Osimertinib Mesylate	14	420	$242,997
Mekinist	Trametinib Dimethyl Sulfoxide	11	330	$163,051
Tafinlar	Dabrafenib Mesylate	11	330	$150,177
Tabrecta	Capmatinib Hydrochloride	12	336	$139,386

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$13	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$19,551	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alfred Jackson Newman, M.D.?

Tedicare shows public-source Medicare data for Alfred Jackson Newman, M.D. (NPI 1831141548), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alfred Jackson Newman, M.D. have ACO affiliation data?

Alfred Jackson Newman, M.D. is shown with ACO affiliation data for Novant Health Accountable Care Organization I, LLC (MSSP, ACO ID A3504).

What billing organization is linked to Alfred Jackson Newman, M.D.?

Alfred Jackson Newman, M.D. is linked to THE PRESBYTERIAN HOSPITAL (billing NPI 1275256422) in the available physician profile data.

Does Alfred Jackson Newman, M.D. have Open Payments data?

Alfred Jackson Newman, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.